FDA Advisory Committee Recommends GE (GE) Healthcare's DaTSCAN (Ioflupane I 123 Injection)

August 11, 2009 5:07 PM EDT Send to a Friend
GE Healthcare (NYSE: GE) announced that the Peripheral and Central Nervous System Drugs advisory committee of the U.S. Food ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login